Park Ha Biological Technology Co. Ltd (BYAH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
(Values in U.S. thousands)
| 10-2025 | 10-2024 | 12-2023 | 10-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,365 | 479 | N/A | 852 | N/A |
| Depreciation Amortization | 109 | 23 | 20 | 20 | N/A |
| Income taxes - deferred | -27 | -22 | N/A | -34 | N/A |
| Accounts receivable | 72 | -99 | N/A | -338 | N/A |
| Accounts payable and accrued liabilities | -12 | -176 | N/A | 69 | N/A |
| Other Working Capital | -92 | 254 | -911 | -911 | N/A |
| Other Operating Activity | 24,399 | 501 | 166 | 468 | 0 |
| Operating Cash Flow | $86 | $961 | $-725 | $127 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -89 | -86 | -23 | -23 | N/A |
| Other Investing Activity | -484 | -423 | 0 | 1,046 | 0 |
| Investing Cash Flow | $-573 | $-508 | $-23 | $1,023 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 7 | 4 | N/A | 61 | N/A |
| Debt Repayment | N/A | -73 | N/A | -776 | N/A |
| Common Stock Issued | 4,278 | 1 | N/A | 38 | N/A |
| Other Financing Activity | -549 | -889 | -677 | 0 | 0 |
| Financing Cash Flow | $3,736 | $-957 | $-677 | $-677 | $N/A |
| Exchange Rate Effect | -8 | 19 | N/A | -14 | N/A |
| Beginning Cash Position | 548 | 1,034 | N/A | 575 | N/A |
| End Cash Position | 3,788 | 548 | N/A | 1,034 | N/A |
| Net Cash Flow | $3,240 | $-486 | $-1,425 | $459 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | 86 | 961 | -725 | 127 | N/A |
| Capital Expenditure | -89 | -86 | N/A | -23 | N/A |
| Free Cash Flow | -3 | 875 | -725 | 104 | 0 |